This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perdikaris, G. Articles by Karayiannakos, P. Search for Related Content PubMed PubMed Citation Articles by Perdikaris, G. Articles by Karayiannakos, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 10 1995, 2289-2294, Vol 39, No. 10
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis

G Perdikaris, H Giamarellou, A Pefanis, I Donta and P Karayiannakos
1st Department of Propedeutic Medicine, Athens University School of Medicine, Laiko General Hospital, Greece.

Using a rabbit model of aortic valve endocarditis, we studied the efficacy of vancomycin alone or in combination with netilmicin and/or rifampin against a methicillin- and gentamicin-resistant strain of Staphylococcus aureus (MGRSA). Antibiotics were given for 6 to 12 days, as follows: vancomycin (15 mg/kg of body weight every 12 h [BID] intravenously), vancomycin plus netilmicin (2.5 mg/kg BID intramuscularly), vancomycin plus rifampin (10 mg/kg BID intramuscularly), and vancomycin plus netilmicin plus rifampin at the same routes, dosages, and schedules mentioned above. Netilmicin was given to two additional groups at a higher dosage (6 mg/kg every 24 h intramuscularly) alone or in combination with vancomycin (15 mg/kg BID intravenously) for 12 days. All regimens resulted in undetectable bacterial counts in a significant proportion of vegetations (except netilmicin alone) or reduced the bacterial counts in the vegetations compared with the counts in the untreated controls (P<0.01 to P<0.001). No resistance to rifampin or netilmicin developed during therapy. It is concluded that in the treatment of experimental aortic valve endocarditis caused by MGRSA (i) vancomycin as monotherapy is as efficacious as the triple combination, (ii) the addition of netilmicin (once daily or BID) to vancomycin does not improve the efficacy of the latter antibiotic, even in the presence of rifampin, and (iii) a 12-day course in more effective than a 6-day one, but not at a statistically significant level.

This article has been cited by other articles:

• Nguyen, H. M., Graber, C. J. (2009). Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?. J Antimicrob Chemother 0: dkp377v1-dkp377 [Abstract] [Full Text]  
• Perlroth, J., Kuo, M., Tan, J., Bayer, A. S., Miller, L. G. (2008). Adjunctive Use of Rifampin for the Treatment of Staphylococcus aureus Infections: A Systematic Review of the Literature. Arch Intern Med 168: 805-819 [Abstract] [Full Text]  
• Siaperas, P., Pefanis, A., Iliopoulos, D., Katsarolis, I., Kyroudi-Voulgari, A., Donta, I., Karayiannakos, P., Giamarellou, H. (2001). Evidence of Less Severe Aortic Valve Destruction after Treatment of Experimental Staphylococcal Endocarditis with Vancomycin and Dexamethasone. Antimicrob. Agents Chemother. 45: 3531-3537 [Abstract] [Full Text]  
• Murphy, T. M., Deitz, J. M., Petersen, P. J., Mikels, S. M., Weiss, W. J. (2000). Therapeutic Efficacy of GAR-936, a Novel Glycylcycline, in a Rat Model of Experimental Endocarditis. Antimicrob. Agents Chemother. 44: 3022-3027 [Abstract] [Full Text]  
• Rochon-Edouard, S., Pestel-Caron, M., Lemeland, J.-F., Caron, F. (2000). In Vitro Synergistic Effects of Double and Triple Combinations of beta -Lactams, Vancomycin, and Netilmicin against Methicillin-Resistant Staphylococcus aureus Strains. Antimicrob. Agents Chemother. 44: 3055-3060 [Abstract] [Full Text]  
• Houlihan, H. H., Stokes, D. P., Rybak, M. J. (2000). Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model. J Antimicrob Chemother 46: 79-86 [Abstract] [Full Text]  
• Climo, M. W., Patron, R. L., Goldstein, B. P., Archer, G. L. (1998). Lysostaphin Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Aortic Valve Endocarditis. Antimicrob. Agents Chemother. 42: 1355-1360 [Abstract] [Full Text]